Rare diseases
Investigational molecules
Locations
Lichtenbergstrasse 1, 85748, Germany
ITM Oncologics GmbH is focused on unresectable locally advanced and metastatic solid tumors, with activity spanning clear cell renal cell carcinoma, pancreatic ductal adenocarcinoma, colorectal cancer, urothelial carcinoma, head and neck cancer, triple negative breast cancer, and squamous non-small cell lung cancer.
The sponsor’s research interest includes tumor types with limited local treatment options and advanced disease burden across genitourinary, gastrointestinal, thoracic, and breast cancer settings.
ITM Oncologics GmbH runs clinical trials in conditions such as Colorectal cancer, Clear cell renal cell carcinoma, Ductal adenocarcinoma of pancreas, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
